Literature DB >> 6544896

Differences in surface sialic acid and galactosyl residues of two autologous human melanoma cell lines.

M Reynier, M Aubery, S Lebec, M Vernay, C Aubert.   

Abstract

Cell surface carbohydrate differences were observed between two human cell lines initiated from primary melanoma and metastasis of the same patient. Although total sialic acid content was similar in both cell lines, neuraminidase-released sialic acid was twice as high in metastatic cells than that of primary cells. One class of Concanavalin A binding sites with similar affinity constant was found in untreated and neuraminidase-treated cells in both cell lines. Before surface sialic acid release, the primary cell line expressed two classes of Ricinus lectin binding sites with high and low affinity; the cell line of metastatic origin had only one class of Ricinus lectin binding sites with low affinity. After neuraminidase treatment, the number of Ricinus lectin binding sites with low affinity increased two- or three-fold in both cell lines, whereas the high-affinity binding sites were not observed in primary cells. The present data indicated that differences in surface sialic acid level modified the Ricinus lectin binding in two human melanoma cell lines. However, the ability of the cells to bind Concanavalin A was not changed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6544896     DOI: 10.1007/bf02934137

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  21 in total

1.  The surface glycoproteins of a mouse melanoma growing in culture and as a solid tumor in vivo.

Authors:  L Warren; I Zeidman; C A Buck
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

2.  Increased sialic acid density in surface glycoprotein of transformed and malignant cells--a general phenomenon?

Authors:  W P van Beek; L A Smets; P Emmelot
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  [Interaction between ricin hemagglutinin and its ligands, galactose and lactose. Microcalorimetry and equilibrium dialysis].

Authors:  C Zentz; J P Frenoy; R Bourrillon
Journal:  Biochimie       Date:  1979       Impact factor: 4.079

4.  Protein-carbonhydrate interaction. 3. Agar gel-diffusion studies on the interaction of Concanavalin A, a lectin isolated from jack bean, with polysaccharides.

Authors:  I J Goldstein; L L So
Journal:  Arch Biochem Biophys       Date:  1965-08       Impact factor: 4.013

5.  Negative cooperativity in regulatory enzymes.

Authors:  A Levitzki; D E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

6.  Altered surface glycoproteins in melanoma cell variants with reduced metastasizing capacity selected for resistance to wheat germ agglutinin.

Authors:  J E Jumblatt; T W Tao; V Schlup; J Finne; M M Burger
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

7.  Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.

Authors:  C Aubert; F Rougé; J R Galindo
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

8.  Identical lectin binding patterns of human melanocytes and melanoma cells in vitro.

Authors:  N Romani; G Schuler; P Fritsch
Journal:  J Invest Dermatol       Date:  1983-04       Impact factor: 8.551

9.  Carbohydrate changes in glycoproteins of a poorly metastasizing wheat germ agglutinin-resistant melanoma clone.

Authors:  J Finne; T W Tao; M M Burger
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

10.  Lactoperoxidase-catalysed iodination of surface proteins on human melanoma cells.

Authors:  G P Roberts
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

View more
  1 in total

1.  The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.

Authors:  A el Battari; J Luis; J M Martin; J Fantini; J M Muller; J Marvaldi; J Pichon
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.